
    
      Glioblastoma face an increased risk of venous or arterial thromboembolism. Furthermore, the
      most frequent immune cells in glioblastoma are tumor associated macrophages, which find
      theirself in an anti-inflammatory (M2) phenotype.

      Increased conjugates between circulating platelets and monocytes reflect an pro-inflammatory
      status.
    
  